Achilles Therapeutics (ACHL) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Achilles Therapeutics has announced changes in its leadership, with Karl Peggs stepping down as Chief Medical Officer to dedicate more time to his roles at UCLH and NIHR UCLH BRC, but he will continue to advise the company. Matilde Saggese, previously Vice President and Medical Director, has been appointed as the Interim CMO.
For further insights into ACHL stock, check out TipRanks’ Stock Analysis page.
